Sentences with phrase «benefits of aspirin»

Scientists at the Institute of Human Genetics at Newcastle University in Britain said the benefits of aspirin were only seen after several years.

Yet few among us today have not benefited from such trials, whether the lessons were positive (e.g., the benefits of an aspirin a day to reduce heart - attack risk) or negative (e.g., the increased risk of cancer associated with long - term hormone - replacement therapy).

Further studies would help to confirm the findings, further elucidate the risks and benefits of aspirin use in this patient population, and potentially inform specific guidelines for treatment of patients with diabetes and heart failure.

«Medical providers must consider whether the potential for bleeding outweighing the potential benefits of aspirin therapy in patients who don't yet meet the guidelines for prescribing aspirin therapy,» said the study's lead and senior author, Ravi S. Hira, M.D. and Salim S. Virani, M.D., Ph.D., of the Baylor College of Medicine in Houston.

«One of the treatments that we used was aspirin, but we know from other trials that the long - term benefit of aspirin in preventing stroke is relatively modest.

They found that almost all of the benefit of aspirin in reducing the risk of another stroke was in the first few weeks, and that aspirin also reduced the severity of these early strokes.

After a mini-stroke, almost all of the benefit of aspirin in reducing the risk of another stroke was found to be in the first few weeks, and researchers also found that aspirin also likely reduced the severity of these early strokes.

Not exact matches

A handful of doctors claim that aspirin's benefits stem from the fact that it is a vital micronutrient which should be reclassified as a vitamin (New Scientist, 7 February 2004, p 36).

«The benefits seen in COMPASS are on the top of other effective therapies such as statins, aspirin, ACE inhibitors and beta blockers, and so their collective impact is substantial.

«Immediate aspirin after mini-stroke substantially reduces risk of major stroke: Benefits of taking aspirin immediately after minor strokes have been underestimated.»

Although aspirin reduces the risk of major cardiovascular events by 19 per cent, a more effective antithrombotic strategy could have major benefits for the large population of patients with stable cardiovascular disease.

The results come during a time when studies investigating aspirin's anti-cancer effects have found evidence to support its benefit, beyond staving off cardiovascular disease or, in oncology, reducing the risk of colorectal cancer.

«Understanding how people respond to aspirin is key in terms of knowing who will benefit from it.»

Adding the antiplatelet drug ticagrelor to aspirin as long - term therapy after a heart attack significantly reduced the rate of subsequent death from cardiovascular causes, heart attack or stroke, with the benefit appearing to accrue for nearly three years, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session.

Small peptides have the benefits of small molecule drugs, like aspirin, and large antibody therapies, like rituximab, with fewer drawbacks.

The study further suggests that NSAIDs such as aspirin, ibuprofen and naproxen have a particularly advantageous effect when taken after diagnosis by colorectal, or CRC, patients without tumor mutation in the KRAS gene (KRAS wild - type tumors): The study shows that NSAID use by this group is associated with a survival benefit of 40 percent.

Objective To identify common genetic markers that may confer differential benefit from aspirin or NSAID chemoprevention, we tested gene × environment interactions between regular use of aspirin and / or NSAIDs and single - nucleotide polymorphisms (SNPs) in relation to risk of colorectal cancer.

Hence, understanding the interrelationship between genetic markers and use of aspirin and NSAIDs, also known as gene × environment interactions, can help to identify population subgroups defined by genetic background that may preferentially benefit from chemopreventive use of these agents and offer novel insights into underlying mechanisms of carcinogenesis.

Previous genetic studies have examined the association of aspirin, NSAIDs, or both with colorectal cancer according to a limited number of candidate genes or pathways.6 - 10 Thus, to comprehensively identify common genetic markers that characterize individuals who may obtain differential benefit from aspirin and NSAIDs, we conducted a discovery - based, genome - wide analysis of gene × environment interactions between regular use of aspirin, NSAIDs, or both and single - nucleotide polymorphisms (SNPs) in relation to risk of colorectal cancer.

Based on these rates, the research team weighed the likelihood of an individual to benefit from aspirin therapy (the potential of the aspirin to prevent a heart attack) against the likelihood of harm (the potential for the aspirin to cause major bleeding).

Routine use of aspirin, NSAIDs, or both for chemoprevention of cancer is not currently recommended because of uncertainty about risk - benefit profile.

But now we're zeroing in on biological markers that will tell us who will benefit from taking aspirin, as well as trying to find the sweet spot of how much aspirin and for how long.

This large study with long - term follow - up was one of the first to examine the potential benefits of different doses and durations of aspirin use.

He also noted that earlier this year, the influential U.S. Preventive Services Task Force «suggested that certain populations at average risk of colon cancer may benefit from taking low - dose aspirin.»

«This article synthesizes what many people in the field are beginning to feel: The risks of daily aspirin therapy exceeds the benefits in people who have not had a heart attack,» says Steven E. Nissen, MD, the chairman of cardiovascular medicine at the Cleveland Clinic, in Ohio.

«Because of some recent studies suggesting that the benefit is not very large, and because aspirin can also have risks (intestinal bleeding or hemorrhagic stroke), the January 2010 recommendations will recommend it mostly for higher - risk people than was the case in the past, when it was recommended for people with more moderate levels of risk and above,» says M. Sue Kirkman, MD, the vice president of clinical affairs for the ADA.

This benefit of taking aspirin was seen after the researchers adjusted for other factors such as sex, age, cancer state, type of treatment, and other health conditions.

The benefits for GI cancers seemed to manifest even with a lower dose of aspirin, starting with half a standard aspirin tablet weekly.

Still, for those at risk for heart disease, the benefits of daily aspirin almost always outweigh the potential risks, says Thomas Lee, MD, professor of medicine at Harvard Medical School and editor in chief of the Harvard Heart Letter.

In your opinion, would ingesting aspirin during such a short fast be of any benefit in prompting AMPK?

At the low doses used to protect the heart, aspirin has only a small effect on inflammation; its heart benefit comes primarily from its ability to reduce the risk of blood clots.

Aspirin being formulated originally from Frederick Bayer would drink white willow nightly and wanted to offer the benefits of white willow to general public.

So, eating a plant - based diet, one might be able to get some of the benefits of taking aspirin, without some of the risks.

In adults age 70 and above there is insufficient data to assess the benefit versus the harm of a preventive daily aspirin.

There is no evidence that non-steroidal anti-inflammatory drugs, such as aspirin, are of any benefit.

According to the American Heartworm Society, use of aspirin in dogs infected with heartworms is no longer recommended due to a lack of evidence of clinical benefit and may be contraindicated.

Researchers at Oxford University noted that while taking aspirin carries a small risk of stomach bleeding, that risk was beginning to be «drowned out» by its benefits in reducing the risk of cancer and the risk of heart attacks.